LIFUS-activated GVs remodel the tumor microenvironment by reducing cancer-associated fibroblast (CAF) abundance, decompressing the matrix, and selectively disrupting CAF-CD8<sup>+</sup> T cell communication via a mechanosensitive Notch1-Jagged1 axis. The gene discussed is JAG1; the disease is cancer.